...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Keytruda trial in the news but doesn't involve Zen

Even though Zen was not involved in this one hopefully it may draw more attention to the other Zen 3694 trial with Keytruda.

https://www.theguardian.com/society/article/2024/jun/02/drug-pembrolizumab-melts-away-tumours-could-replace-surgery-for-bowel-cancer-say-doctors

Share
New Message
Please login to post a reply